ResearcherGifu University HospitalActive in the last 2 years
Naoki Mita
Matched on OpenAlex author ID A5056808063. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperative Endoscopic Biliary Obstruction in Pan… Co-author DOI 10.1007/s10620-026-10136-z↗
- Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving multi-agent chemotherapy: A single center, … Co-author DOI 10.1016/j.pan.2022.01.010↗
- The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIRINOX therapy. Co-author DOI 10.1017/s0007114520003463↗
- Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Cen… Co-author DOI 10.3390/jcm10132848↗
- Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure. Co-author DOI 10.3390/jcm8060761↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shinya Uemura · 5 shared papers, 2019–2026 · strength 0.82
- Paper 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperati… DOI 10.1007/s10620-026-10136-z↗
- Paper Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving mul… DOI 10.1016/j.pan.2022.01.010↗
- Paper The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIR… DOI 10.1017/s0007114520003463↗
- Takuji Iwashita · 5 shared papers, 2019–2026 · strength 0.82
- Paper 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperati… DOI 10.1007/s10620-026-10136-z↗
- Paper Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving mul… DOI 10.1016/j.pan.2022.01.010↗
- Paper The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIR… DOI 10.1017/s0007114520003463↗
- Masahito Shimizu · 5 shared papers, 2019–2026 · strength 0.82
- Paper 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperati… DOI 10.1007/s10620-026-10136-z↗
- Paper Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving mul… DOI 10.1016/j.pan.2022.01.010↗
- Paper The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIR… DOI 10.1017/s0007114520003463↗
- Hironao Ichikawa · 4 shared papers, 2021–2026 · strength 0.73
- Paper 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperati… DOI 10.1007/s10620-026-10136-z↗
- Paper Impact of Controlling nutritional status (CONUT) in patients with unresectable advanced pancreatic cancer receiving mul… DOI 10.1016/j.pan.2022.01.010↗
- Paper The impact of sarcopenia and decrease in skeletal muscle mass in patients with advanced pancreatic cancer during FOLFIR… DOI 10.1017/s0007114520003463↗
- Mitsuru Okuno · 2 shared papers, 2019–2026 · strength 0.35
- Paper 11.5-Fr Large-Bore Plastic Stents Versus Fully Covered Self-Expandable Metallic Stents for the Management of Preoperati… DOI 10.1007/s10620-026-10136-z↗
- Paper Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line … DOI 10.3390/jcm8060761↗
- Akinori Maruta · 1 shared paper, 2026 · strength 0.26
- Kensaku Yoshida · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.